ask="2.50"
ask_size="1000"
average_daily_volume="183063"
bid="2.25"
bid_size="500"
book_value="1.48"
change="+0.00"
change_from_200_day_moving_average="0.49"
change_from_50_day_moving_average="0.11"
change_from_52_week_high="-1.05"
change_From_52_week_low="1.20"
change_in_percent="+0.00%"
close="2.30"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.33"
ebitda="-17.29M"
eps_estimate_current_year="-1.10"
eps_estimate_next_quarter="-0.20"
eps_estimate_next_year="-0.54"
ex_dividend_date="N/A"
float_shares="13363000"
high="2.35"
high_52_weeks="3.35"
last_trade_date="3/2/2017"
last_trade_price="2.30"
last_trade_size="187"
last_trade_time="4:00pm"
low="2.25"
low_52_weeks="1.10"
market_capitalization="43.44M"
moving_average_200_day="1.81"
moving_average_50_day="2.19"
name="Cancer Genetics
Inc."
notes="N/A"
one_year_target_price="6.58"
open="2.25"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="+26.98%"
percent_change_from_50_day_moving_average="+5.04%"
percent_change_from_52_week_high="-31.34%"
percent_change_from_52_week_low="+109.09%"
previous_close="2.30"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.56"
price_per_sales="1.72"
revenue="25.30M"
shares_outstanding="18887000"
short_ratio="2.35"
stock_exchange="NCM"
symbol="CGIX"
volume="70753"
weeks_range_52="1.10 - 3.35"
